Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: Impact on poor prognosis and early recurrence

British Journal of Cancer

Volumn 90, Issue 2, 2004, Pages 436-442

  Gu, C ^a   Oyama, T ^b   Osaki, T ^a   Li, J ^b   Takenoyama, M ^b   Izumi, H ^b   Sugio, K ^b   Kohno, K ^b   Yasumoto, K ^b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

GalNAc T3; Lung adenocarcinoma; Prognosis; Recurrence

Indexed keywords

ISOENZYME; N ACETYLGALACTOSAMINYLTRANSFERASE; N ACETYLGALACTOSAMINYLTRANSFERASE 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOPLASM; DISEASE MARKER; DISEASE SEVERITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME LOCALIZATION; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 1342322762     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601531     Document Type: Article

References (38)

1. Bennett EP, Hassan H, Clausen H (1996) cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N- acetylgalactosaminyltransferase, GalNAc-T3. J Biol Chem 271: 17006-17012
2. Bennett EP, Hassan H, Mandel U, Mirgorodskaya E, Roepstorff P, Burchell J, Taylor-Papadimitriou J, Hollingsworth MA, Merkx G, van Kessel AG, Eiberg H, Steffensen R, Clausen H (1998) Cloning of a human UDP-N-acetyl-alpha-D- galactosamine: polypeptide N-acetyl-galactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J Biol Chem 273: 30472-30481
3. Bennett EP, Hassan H, Hollingsworth MA, Clausen H (1999a) A novel human UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. FEES Lett 460: 226-230
4. Bennett EP, Hassan H, Mandel U, Hollingsworth MA, Akisawa N, Ikematsu Y, Merkx G, van Kessel AG, Olofsson S, Clausen H (1999b) Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D- galactosamine: Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy. J Biol Chem 274: 25362-25370
5. Bolscher JG, Schallier DC, van Rooy H, Storme GA, Smets LA (1988) Modification of cell surface carbohydrates and invasive behavior by an alkyl lysophospholipid. Cancer Res 48: 977-982
6. Cao Y, Karsten UR, Liebrich W, Haensch W, Springer GF, Schlag PM (1995) Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluation. Cancer 76: 1700-1708
7. Clausen H, Bennett EP (1996) A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation. Glycobiology 6: 635-646
8. Cox D (1972) Regression models and life tables. J R Stat Soc 34: 187-220
9. Diez M, Torres A, Maestro ML, Ortega MD, Gomez A, Pollan M, Lopez JA, Picardo A, Hernando F, Balibrea JL (1996) Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer. Br J Cancer 73: 1248-1254
10. Fogel M, Altevogt P, Schirrmacher V (1983) Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J Exp Med 157: 371-376
11. Ginsberg R, Yokes E, Raben A (1997) Non-small cell lung cancer. In Cancer, Principles and Practice of Oncology, De Vita Jr V, Helleman S, Rosenberg S (eds) pp 858-911. Philadelphia: Lippencott-Raven
12. Gu C, Osaki T, Oyama T, Inoue M, Kodate M, Dobashi K, Oka T, Yasumoto K (2002) Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and survival. Ann Surg 235: 133-139
13. Hagen FK, Van Wuyckhuyse B, Tabak LA (1993) Purification, cloning, and expression of a bovine UDP-GalNAc: polypeptide N-acetyl- galactosaminyltransferase. J Biol Chem 268: 18960-18965
14. Hara N, Nakanishi Y, Izumi M (2000) Epidemiology of lung cancer in Japan. Nippon Rinsho 58: 1005-1011
15. Ho JJ, Siddiki B, Kim YS (1995) Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin in a pancreatic cancer cell line. Cancer Res 55: 3659-3663
16. Homa FL, Hollander T, Lehman DJ, Thomsen DR, Elhammer AP (1993) Isolation and expression of a cDNA clone encoding a bovine UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase. J Biol Chem 268: 12609-12616
17. Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S, Kim YS (1990) Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66: 1960-1966
18. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
19. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48: 6-29
20. Little AG, DeMeester TR, Ferguson MK, Skinner DB, Hoffman PC, Skosey C, Blough RR, Golomb HM (1986) Modified stage I (T1N0M0, T2N0M0), non-small cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy. Surgery 100: 618-621
21. Matsushita Y, Nakamori S, Seftor EA, Hendrix MJ, Irimura T (1991) Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric LeX antigen. Exp Cell Res 196: 20-25
22. Mountain C (1997) Revisions in the International System for Staging Lung Cancer. Chest 111: 1710-1717
23. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T (1994) MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 106: 353-361
24. Niklinski J, Furman M, Laudanski J, Kozlowski M. (1992) Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer. Eur J Cancer Prev 1: 401-416
25. Nomoto M, Izumi H, Ise T, Kato K, Takano H, Nagatani G, Shibao K, Ohta R, Imamura T, Kuwano M, Matsuo K, Yamada Y, Itoh H, Kohno K (1999) Structural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells. Cancer Res 59: 6214-6222
26. Ogawa J, Sano A, Koide S, Shohtsu A (1994) Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl LewisX, and sialyl Lewis(a) in lung cancer. J Thorac Cardiovasc Surg 108: 329-336
27. Ohgami A, Tsuda T, Osaki T, Mitsudomi T, Morimoto Y, Higashi T, Yasumoto K (1999) MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence. Ann Thorac Surg 67: 810-814
28. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 35: 1-39
29. Phillips ML, Nudelman E, Gaeta FC, Perez M, Singhal AK, Hakomori S, Paulson JC (1990) ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 250: 1130-1132
30. Rice GE, Bevilacqua MP (1989) An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246: 1303-1306
31. Sutherlin ME, Nishimori I, Caffrey T, Bennett EP, Hassan H, Mandel U, Mack D, Iwamura T, Clausen H, Hollingsworth MA (1997) Expression of three UDP-N-acetyl-alpha-D-galactosamine: polypeptide GalNAc N-acetylgalactosaminyl transferases in adenocarcinoma cell lines. Cancer Res 57: 4744-4748
32. Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R (1993) Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53: 354-361
33. Ten Hagen KG, Hagen FK, Balys MM, Beres TM, Van Wuyckhuyse B, Tabak LA (1998) Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family. J Biol Chem 273: 27749-27754
34. von Mensdorff-Pouilly S, Petrakou E, Kenemans P, van Uffelen K, Verstraeten AA, Snijdewint FG, van Kamp GJ, Schol DJ, Reis CA, Price MR, Livingston PO, Hilgers J (2000) Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. Int J Cancer 86: 702-712
35. Walz G, Aruffo A, Kolanus W, Bevilacqua M, Seed B (1990) Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science 250: 1132-1135
36. Wandall HH, Hassan H, Mirgorodskaya E et al. (1997) Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. Biol Chem 272: 23503-23514
37. Wesseling J, van der Valk SW, Hilkens J (1996) A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 7: 565-577
38. White T, Bennett EP, Takio K, Sorensen T, Bonding N, Clausen H (1995) Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase. J Biol Chem 270: 24156-24165